Cargando...
Diffuse erythematous rash after teneligliptin therapy: A case report
We report a yet unreported, adverse effect of teneligliptin [Dipeptidyl peptidase IV inhibitor (DPP IV)] presenting as diffuse pruritic erythematous rash, in a patient, 2 days after initiation of the drug. The rash waned off after the discontinuation of the drug without any residual lesion.
Gardado en:
| Publicado en: | J Family Med Prim Care |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6293926/ https://ncbi.nlm.nih.gov/pubmed/30613561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/jfmpc.jfmpc_283_18 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|